Figure 3 | Prostate Cancer and Prostatic Diseases

Figure 3

From: The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy

Figure 3

CTCpos status at baseline and at any time point correlates with a decrease in time to biochemical failure following adjuvant or salvage radiotherapy. (a) Percentage of patients with circulating tumor cells (CTCs) absent (CTCneg/-; n=45) versus CTCs present (CTCpos/+; n=9) at baseline who are biochemical failure free over a 36-month period. (b) Percentage of patients with CTCneg (n=38) at all time points versus CTCpos (n=16) at any time point who are biochemical failure free over a 36-month period.

Back to article page